Skip to main content
. Author manuscript; available in PMC: 2024 Mar 21.
Published in final edited form as: Travel Med Infect Dis. 2017 Dec 11;21:3–20. doi: 10.1016/j.tmaid.2017.12.005
Number Searches
#1 Atovaquone[mesh] OR atovaquone[tiab]
#2 Proguanil[mesh] OR proguanil[tiab]
#3 Atovaquone, proguanil drug combination[Supplementary Concept] OR malarone[tiab] OR hydroxynaphthoquinone[tiab] OR Mepron [tiab] OR Wellvone[tiab] OR atovaquone/proguanil[tiab] OR Atovaquone and Proguanil[tiab] OR Atovaquone + proguanil[tiab]
#4 Chemoprevention[Mesh:NoExp] OR prevention and control[Subheading] OR chemoprophylaxis[tiab] OR prophylaxis[tiab] OR chemoprevention[tiab] OR pharmacokinetics[Mesh] OR pharmacokinetics[Subheading] OR pharmacokinetics[tiab] OR Half-Life [Mesh] OR half-life*[tiab] OR halflife*[tiab] OR duration[tiab] OR area under curve[mesh] OR absorption[mesh] OR PK[tiab] OR PPK [tiab] OR tmax[tiab] OR cmax[tiab] OR AUC[tiab] OR “area under the curve”[tiab] OR clearance[tiab] OR elimination[tiab] OR “volume of distribution”[tiab] OR “drug level”[tiab] OR absorption[tiab] OR serum concentration[tiab] OR plasma concentration[tiab]
#5 #1 AND #2
#6 #3 OR #5
#7 #4 AND #6